Skip to main content


Pachyonychia Congenita Market Size and Share Analysis Pachyonychia Congenita (PC) is a rare genetic disorder characterized by thickened nails, painful calluses on the soles of the feet, and other skin abnormalities. It is caused by mutations in specific genes, leading to keratin protein dysfunction. The market outlook for Pachyonychia Congenita is focused on improving patient care through symptom management and developing targeted therapies to address the underlying genetic cause. Currently, there are no specific treatments for PC, but ongoing research and development activities are anticipated to transform the therapeutics market outlook in the upcoming years.